These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7717070)

  • 21. [Effect of protopine on rabbit platelet function].
    Ma GY; Zhang ZZ; Chen ZH
    Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):367-71. PubMed ID: 7801784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylation.
    Karpatkin S; Pearlstein E; Salk PL; Yogeeswaran G
    Prog Clin Biol Res; 1982; 89():445-77. PubMed ID: 7111309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of benzamidine derivatives on thrombin-induced platelet reactions.
    Glusa E; Hoffmann A; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):98-106. PubMed ID: 6177615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual effects of 5-hydroxytryptamine on stable analogue of thromboxane A2-induced aggregation and release reaction in rabbit platelets.
    Li BY; Zhou YC; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):171-4. PubMed ID: 10374646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory role of protein tyrosine phosphorylation in platelet activating factor-induced signal transduction in platelets.
    Zeng S; Yi FX; Guo ZG
    Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):157-61. PubMed ID: 10437164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions.
    Shen Z; Dong Z; Cheng P; Li L; Chen Z; Liu J
    Planta Med; 2003 Jul; 69(7):605-9. PubMed ID: 12898414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
    Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
    Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
    Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK
    Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.
    Storey RF; Newby LJ; Heptinstall S
    Platelets; 2001 Nov; 12(7):443-7. PubMed ID: 11674863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of local anaesthetics with blood platelet aggregation.
    Jancinová V; Nosál' R; Benes L
    Drugs Exp Clin Res; 1986; 12(9-10):857-60. PubMed ID: 3792211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of platelet-activating factor (PAF) on the collagen-induced whole blood aggregation].
    Oura Y
    Rinsho Byori; 1994 Jan; 42(1):63-9. PubMed ID: 8107285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
    Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
    Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
    Jagroop IA; Mikhailidis DP
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):295-302. PubMed ID: 18445610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of the activation of rabbit platelets induced by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activation factor)].
    Kozlov VK; Filatova LV; Kulikov VI; Markosian RA; Bergel'son LD
    Biull Eksp Biol Med; 1985 Oct; 100(10):410-2. PubMed ID: 4052603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of disodium quercetin-7,4'-disulfate on aggregation of pig platelets induced by thrombin and its mechanism.
    Liu W; Liang NC
    Acta Pharmacol Sin; 2000 Aug; 21(8):737-41. PubMed ID: 11501184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets.
    Bailey SR; Andrews MJ; Elliott J; Cunningham F
    Res Vet Sci; 2000 Apr; 68(2):175-80. PubMed ID: 10756136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.